Children Hepatitis A Vaccine

As a developer and supplier of Children Hepatitis A Vaccine, AIM Action Biopharmaceutical Co., Ltd. utilizes internationally certified human diploid cell culture and inactivation processes to provide lasting protection for children aged 1-15 years (including 15 years old). Currently, this children's formulation has been included in the procurement and inventory catalogs of many local disease control systems, making it a reassuring choice for protecting children's health and building family immunity.

Why Do Kids Need This Vaccine?

The AIM Action’s Children Hepatitis A Vaccine is a preventive product specifically optimized for children aged 1 to 15, tailored to their immune development.

Unlike adult formulations, this vaccine contains precisely measured antigens per 0.5ml, effectively stimulating the immune system to produce sufficient protective antibodies while minimizing adverse reactions.

Children, with their strong curiosity and frequent hand-to-mouth contact, are particularly susceptible to hepatitis A virus. The World Health Organization recommends hepatitis A vaccination for individuals aged 12 months and older.

Following the scientific "two-dose, long-term protection" protocol (0 and 6 months), this vaccine provides robust liver protection for children, giving parents greater peace of mind.

Core Features: A Safeguard for Growth

1. Mild Dose, Exceptional Response: The antigen dose specifically designed for children achieves a scientific balance between immune efficacy and safety. It effectively stimulates the body to produce highly protective antibodies while minimizing common side effects like fever and pain.

2. Scientific immunization procedure, lasting protection: The standard 0-6-month two-dose regimen induces long-term immune memory. Studies show that completing the full vaccination course provides protection lasting at least 14-20 years, or even longer.

3. Process Safety and Pure Reliability: Utilizing human diploid cell culture eliminates animal-derived risks. Combined with inactivation technology, the vaccine contains no live viruses, ensuring exceptional safety—particularly suitable for children whose immune systems are still developing.

4. Rapid response, emergency protection: In the event of an emergency (e.g. cases in a nursery or school), vaccination can rapidly produce antibodies to provide emergency protection.

Hepatitis A inactivated vaccine vaccinated earlier provides earlier protection.

Main Application Scenarios

Routine immunization for children of appropriate age: Children Hepatitis A Vaccine provides basic protection against hepatitis A for all healthy children of 1-15 years old (including 15 years old) and is an important part of the childhood immunization programme.

Health preparation for daycare and school: Vaccination before entering group life can effectively prevent potential transmission risks in crowded places such as kindergartens and schools.

Family and travel protection: Provide children with the necessary travel health protection when planning to travel to or visit relatives in areas where hepatitis A is endemic.

Emergency vaccination in high-risk settings: Emergency vaccination of children at risk of infection aged 1-15 years old (including 15 years old) in the event of an outbreak of hepatitis A to rapidly establish an immune barrier.

Instructions for Use

Each vial or syringe contains 0.5 ml of vaccine. The single dose for children is 0.5 ml, containing 320 EU of hepatitis A virus antigen.

(1) Shake well before use. Administer by intramuscular injection into the deltoid muscle of the upper arm.

(2) Children aged 1-15 years (including 15 years old) should receive the children's dose. The primary immunization consists of one dose, followed by a booster dose 6 months later. Each dose is 0.5 ml.